HOOKIPA PHARMA INC. Deferred Tax Assets, Valuation Allowance
HOOKIPA PHARMA INC. had Deferred Tax Assets, Valuation Allowance of $93.38 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2025-02-28
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $93.38M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $89.31M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $65.77M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $53.73M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2024-12-31 | $93.38M 10-K · filed 2025-02-28 |
| 2023-12-31 | $89.31M 10-K · filed 2025-02-28 |
| 2022-12-31 | $65.77M 10-K · filed 2025-02-28 |
| 2021-12-31 | $53.73M 10-K · filed 2025-02-28 |
| 2020-12-31 | $46.06M 10-K · filed 2024-03-22 |
| 2019-12-31 | $32.58M 10-K · filed 2023-03-15 |
| 2018-12-31 | $19.16M 10-K · filed 2022-03-24 |
| 2017-12-31 | $13.79M 10-K · filed 2021-03-18 |
| 2016-12-31 | $8.38M 10-K · filed 2020-03-19 |